Correlation Between GlaxoSmithKline PLC and American Funds

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and American Funds at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and American Funds into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and American Funds The, you can compare the effects of market volatilities on GlaxoSmithKline PLC and American Funds and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of American Funds. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and American Funds.

Diversification Opportunities for GlaxoSmithKline PLC and American Funds

-0.91
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between GlaxoSmithKline and American is -0.91. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and American Funds The in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on American Funds and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with American Funds. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of American Funds has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and American Funds go up and down completely randomly.

Pair Corralation between GlaxoSmithKline PLC and American Funds

Considering the 90-day investment horizon GlaxoSmithKline PLC is expected to generate 5.91 times less return on investment than American Funds. In addition to that, GlaxoSmithKline PLC is 1.19 times more volatile than American Funds The. It trades about 0.02 of its total potential returns per unit of risk. American Funds The is currently generating about 0.11 per unit of volatility. If you would invest  5,414  in American Funds The on August 31, 2024 and sell it today you would earn a total of  2,775  from holding American Funds The or generate 51.26% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy99.73%
ValuesDaily Returns

GlaxoSmithKline PLC ADR  vs.  American Funds The

 Performance 
       Timeline  
GlaxoSmithKline PLC ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GlaxoSmithKline PLC ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
American Funds 

Risk-Adjusted Performance

16 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in American Funds The are ranked lower than 16 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly weak technical and fundamental indicators, American Funds may actually be approaching a critical reversion point that can send shares even higher in December 2024.

GlaxoSmithKline PLC and American Funds Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GlaxoSmithKline PLC and American Funds

The main advantage of trading using opposite GlaxoSmithKline PLC and American Funds positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, American Funds can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in American Funds will offset losses from the drop in American Funds' long position.
The idea behind GlaxoSmithKline PLC ADR and American Funds The pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Other Complementary Tools

Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Money Managers
Screen money managers from public funds and ETFs managed around the world
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.